Abiopharma

News list

Lammers Paul 🟢 acquired 2.0K shares of Decoy Therapeutics Inc. (DCOY) Transaction Date: Aug 31, 2026 | Filing ID: 000003

Full text

News bot Sept. 2, 2026, 9:42 p.m.
🔍 Lammers Paul (Executive)

Company: Decoy Therapeutics Inc. (DCOY)

Report Date: 2026-08-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 2,000
Detailed Transactions and Holdings:
- Acquired 2,000 shares of Common Stock (Direct)
  Date: 2026-08-31 | Code: A | equity_swap_involved: false | shares_owned_after: 2,001.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan, 100 percent will vest on August 30, 2027.
- F2: Shares beneficially owned following the transaction have been adjusted to reflect the reverse stock splits effective on August 15, 2025 and March 6, 2026.